---
title: AsPC-1 Orthotopic Model - TD2 Precision Oncology
description: AsPC-1 is a pancreatic adenocarcinoma cell line widely used for studying pancreatic cancer and testing therapeutic interventions.
image: https://td2inc.com/hubfs/Assets/GraphsFigures/aspc-1.png
---
×
[](https://td2inc.com/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
# AsPC-1 Orthotopic Model
**Synonyms:** -
AsPC-1 is a well-established human pancreatic adenocarcinoma cell line used as a model for studying pancreatic cancer. It retains characteristics of pancreatic adenocarcinoma, including epithelial morphology, invasiveness, and expression of tumor markers. AsPC-1 is commonly employed in pancreatic cancer research to investigate disease mechanisms, evaluate therapeutic responses, and test novel treatment approaches. This cell line aids in understanding pancreatic cancer biology and the development of improved strategies for patient management.
## Model Details
**Cancer Type:** Pancreatic Cancer
**Model Name:** AsPC-1
**Mouse Strain:** Nu/Nu
**Treatment Data Available:** Chemotherapy (Gemcitabine, Abraxane)
## AsPC-1 Survival
Survival of AsPC-1 after orthotopic intrapancreatic injection of Nu/Nu mice (n=5)
### Request Additional Syngeneic Model Data
## CONTACT US
## Get Started.
Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.
[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
Office
13208 E. Shea Blvd,
Suite 100
Scottsdale, AZ 85259
Phone
(602) 358-8300
Connect with us
-
-
© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)